SynthesisPloS one2022

Efficacy and safety of saroglitazar for the management of dyslipidemia: A systematic review and meta-analysis of interventional studies.

Manik Chhabra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.